drugset
drugset / Trial / NCT03884491

A Study Investigating Formulations of Vortioxetine Applied Under the Tongue in Healthy Subjects

NCT03884491 ↗

Phase 1 Completed 16 enrolled H. Lundbeck A/S
SequentialOpen-labelTreatment

Summary

This study investigates formulations of vortioxetine applied under the tongue

Timeline

Start
2019-03-18
Primary completion
2019-06-25
Completion
2019-07-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Vortioxetine Unknown 5 mg Intravenous
Subject Vortioxetine Unknown 10 mg Intravenous
Subject Vortioxetine Unknown 25 mg Intravenous

Indications

No indication recorded.